I understand why cryonics used to feel like an American idea to people in Europe.

For a long time, that was more or less true in practice. You could agree with the idea, arrange the funding and still face a rather uncomfortable question.

What happens if I die thousands of kilometres from the people expected to preserve me?

That was not a theoretical objection. In our member interviews, we repeatedly heard some version of the same concern. People had known about cryonics for years, sometimes much longer, but the distance made the arrangement feel fragile.

Then a serious European option appeared, and the decision became real.

This is why being based in Europe matters. Not because a European address makes cryopreservation certain. It matters because the difficult first part of the procedure can be organised around where European members actually live.

Europe stopped being the missing piece

Tomorrow.bio was founded in Berlin because Europe needed its own cryopreservation infrastructure.

We did not want to build a European sales office for a procedure happening somewhere else. We built response teams, custom ambulances, field equipment, operating protocols and a route to long-term storage in Switzerland.

There is a very big difference between those two things.

A contract can cross an ocean instantly. A medical response cannot.

After legal death, circulation stops and warm ischaemia begins. The quality of the starting conditions depends heavily on how quickly a trained team can begin standby and stabilisation.

Distance is therefore not a minor inconvenience. It determines how many vehicles, flights, handovers and outside parties stand between the patient and the first capable team.

Tomorrow.bio now operates with teams, ambulances and local support across Europe. We also use a pre-deploy-and-fly model when a member is at serious risk but the timing remains uncertain.

In plain English, we can move equipment and an ambulance close to the member first, then fly the medical team when the situation becomes urgent. We do not need to improvise the entire chain after a death has already occurred.

This is the part that changed the decision for several people we interviewed. A regional provider made the logistics credible enough for them to stop waiting.

A European provider does not make cryonics local by changing the website language. It makes it local by putting the procedure closer to the patient.

The procedure can start before Switzerland

People sometimes imagine the patient must reach the storage facility before the serious work begins.

That would be a terrible model for Europe. The continent is compact, but it is not that compact.

Our ambulances are mobile operating environments. When circumstances allow, the team can begin cooling, circulatory support, medication and then whole-body field cryoprotection in the country where the member dies.

Cryoprotective perfusion replaces blood and other circulating fluid with a solution intended to suppress ice formation during later cooling. Doing this before long-distance transport is one of the most important advantages of the European system we built.

Once field cryoprotection is complete, the patient can be cooled further while the funeral partner and local authorities finish the transport documents.

We have had cases where this paperwork took days. The local funeral partner kept the patient at its premises and replenished dry ice every day until transport to Switzerland could continue.

Was waiting ideal? Of course not. But it happened after the essential field procedure rather than before it.

That distinction is easy to miss if you think of the ambulance as nothing more than a vehicle. It is why we invested in specialised equipment rather than building a service that depends on rushing an untreated patient across several borders.

The final transport is usually the straightforward part. Once the required documents and permits are in hand, we coordinate the funeral partner, airline or road transport, customs where relevant, and reception in Switzerland.

The member is not expected to negotiate with an airline during a family emergency. We take care of the operational chain and ask the member or family only for the personal documents that we or the funeral partner need.

The full sequence is described in what happens when you need us. The cross-border details are explained in logistics and transportation.

Free practical tool

How ready is your plan?

Use this short assessment to find practical gaps in your cryopreservation arrangements.

Loading the interactive tool...

The boring local knowledge is part of the service

Europe is not one country. This sounds obvious, but people regularly talk about European law as if one set of rules controlled every hospital, funeral home and death certificate from Lisbon to Helsinki.

It does not.

Every case touches national rules and local practice. Who releases the body? Which authority signs the export document? Does the funeral home understand dry-ice handling? What will the airline accept? Which document must be an original?

None of this is exciting. It is still part of doing the job well.

A European provider accumulates useful operational memory. We know which questions to ask, which documents to start early and when a local funeral partner needs to speak directly with an authority.

We have moved patients from different European countries and from outside Europe to Switzerland. Transport bureaucracy can be slow, but it is a process we know how to manage.

The member's responsibility is much smaller: keep contact details and funding current, make the relevant wishes clear, provide requested documents and tell us early when a serious medical situation develops.

Early notice gives us time to choose between remote monitoring, pre-deployment and full standby. It can also give a hospital, care home or funeral partner time to understand the plan before everyone is under pressure.

The European legal framework still varies by country. We work case by case because that is what the real world requires, not because the system is improvised.

The chain ends in Switzerland for a reason

After field cryoprotection and transport, the patient reaches the European Biostasis Foundation facility in Rafz, Switzerland.

EBF is Tomorrow.bio's sister organisation and the long-term storage facility for our members. The purpose-built building has been operational since 2022 and combines medical, imaging, cooling, research and storage infrastructure in one place.

It is close to the German border and around 30 to 40 minutes from Zurich Airport. That location keeps the final destination connected to the rest of Europe without placing long-term storage inside a commercial office or rented warehouse.

The institutional structure matters too.

Tomorrow.bio manages membership, response, cryoprotection and transport. EBF owns and operates the Swiss facility. The Patient Care Foundation holds the patient-care capital and remains responsible for the patient's body and funds.

Those roles are separated so that long-term care does not depend on the ordinary life cycle of one company. You can see the complete arrangement in the Tomorrow.bio ecosystem and the article about the long-term storage facility.

This is what a European provider changes: not one isolated leg of the journey, but the coherence of the whole chain.

The same organisation preparing with the member also plans the response. The field team uses procedures designed for the transport that follows. The patient then arrives at the Swiss facility built to complete cooldown, perform quality checks and provide long-term care.

That does not solve the scientific uncertainty at the heart of cryonics. No provider can promise that revival will become possible.

It also cannot guarantee that every death will be predictable, that a family will cooperate or that local authorities will never delay a case.

But these limits are not an argument for accepting unnecessary distance. Cryonics is uncertain enough already. We should remove every operational disadvantage that we know how to remove.

For someone in Europe, choosing a European provider means choosing a system built around European reality: closer response, field cryoprotection, experienced cross-border coordination and purpose-built Swiss storage.

That is not a cosmetic advantage. It changes what can happen when the service is actually needed.

TL;DR: For a European member, a European provider brings response, field cryoprotection and cross-border coordination closer to the patient. It does not promise revival, but it removes avoidable distance from the procedure.

Further reading